Thymus Peptide Vladonix® 60 Capsules

Peptide Bio-regulators, gene switches that could replace stem cells!
This former Russian military secret is now available to the public!

 

Russian peptide technology was founded during the Cold War years- to help protect elements of the then Soviet forces.

 

Today Professor Vladimir Khavinson is the President of the European Academy of Gerontology and Geriatrics, but in the 1980’s he was a Colonel in the Soviet Union military medical corps. At the time, he and his team were approached by Kremlin officials, they wanted them to find a way to protect their troops from a myriad of problems; issues such as radiation for submariners in nuclear submarines to troops that may be blinded from known, (but thankfully unused) new weapons such as battlefield lasers.

 

What their secret research uncovered - that was used for two decades on many thousands of men and women - was a remarkable link between short chain peptides and DNA.

 

Now their published research is in the open and it identifies that each organ / gland / tissue uses a highly specific short chain peptide to act as a ‘short cut’ to initiate protein synthesis. These peptides can be found in food and unlike proteins they can enter the blood through the stomach. Through a comprehensive list of patents and even copyrighted PowerPoint slides, the Russian research group are showing that each of the concentrated peptide bioregulators so far examined interact with particular strands of DNA - effectively and very specifically activating repair and regenerative processes.

 

This is a remarkable story since what we are describing here are individualised gene switches and since they have been tested for many years on thousands of individuals, without report of any serious side effects or contraindications to date, they could be set to ‘out do’ stem cells. Why? Because this peptide therapy is relatively cheap, highly specific, can be taken orally and doesn’t require any suppression of the immune system to operate fully.

 

Professor Khavinson and his award winning team at the St Petersburg Institute of Biogerontology have discovered that each organ / gland has a biological reserve and despite the origin of the tissue they have studied, incredibly each one is always set at 42%

 

Even dosing doesn’t need to be daily, these peptide bioregulators have been shown to act even after a simple course of 2 capsules daily for 10-days. Healthy individuals only being encouraged to repeat the course 6-months later, although of course depending on the need this course can be repeated every 3-months, 2-months or 1-month if necessary. But compared to a hormone replacement therapy this is interesting, since hormones would require almost daily application. But these peptide bioregulators aren’t hormones, they are acting on the gland concerned to ‘encourage’ it to become active and effectively ‘younger’ by triggering activating the DNA responsible.

 

Peptide supplements
For many years the peptide preparations were available only as medicines, in the form of injections. However some years ago Prof. Khavinson and the Russian St. Petersburg Institute of Bioregulation and Gerontology created dietary supplements that can also reduce peptide deficiency and restore peptide-protein cycle in cells. They can be divided into natural (Cytomaxes) and synthesized (Cytogens) russian peptide bioregulators.

Natural russian peptide bioregulators (Cytomaxes)
Natural russian peptide bioregulators is a group of peptides of less than 50 amino acids and with a molecular mass of less than 5 kDa, free from foreign DNA or protein substance, extracted from organs and tissues of young calves by a patented method of thorough filtering. 5 kDa is very little. The molecular mass of DNA fragments and proteinaceous infectious particles, the prions, are several times bigger than that. Therefore these natural russian peptide supplements are extremely clean products. They do not have any immunogenic or mutagenic properties.
Inside the gastrointestinal tract the natural russian peptide bioregulators break down into amino acids and di-, tri- and tetrapeptides that match the DNA in a complementary way and activate protein synthesis in the respective body system. Their performance is gentle and gradual. Their effect continues to grow even after finishing the supplementation course and lasts up to 4-6 months until the peptide-protein cycle is impaired again.

Synthesized peptide bioregulators (Cytogens)
The analysis of natural peptides was used to detect the most active peptide from a group, which was later replicated in a lab. Synthesized (Cytogens) peptide bioregulators supplement contains only one peptide molecule whereas natural one includes a group of molecules. Synthesized peptides have an immediate impact compared to natural peptides and have a faster, yet more short-lived effect (1.5-2 months). Such peptides are typically used to start the initial peptide deficiency treatment. However, it is advised to switch to natural (Cytomaxes) peptides as a follow-up course.

Both types of peptides are efficient, safe to use, have no side effects and are compatible among themselves and with other products. As for the choice between natural and synthesized russian peptides, it depends on a particular situation. However, in most cases synthesized peptides, if available, are administered prior to the use of natural peptides.

Buy Russian natural peptide bioregulators online from MHC an official distributor in the US.
 

What is a peptide bioregulator?
A peptide is a short chain of amino acids, identified by the fact that it is shorter than a protein, and so can be absorbed easily via the digestive system. Each organ or bodily function has its own unique peptide bioregulator.
Peptide bioregulators have been shown to shortcut the protein synthesis process by interacting directly with cell DNA – meaning that organs can build and repair tissues easier and quicker when peptide bioregulators are active.

 

What combination of peptides would be best to consider for the elderly in general?
Glandokort® - adrenal peptide, Vladonix® -thymus peptide and Ventfort® - blood vessels peptide.

 

How to correct disorders of the immune system?
Combine Vladonix® - thymus peptide, Endoluten® - pineal peptide and Ventfort® -blood vessel peptide

 

What combination of peptides should i take?
According to Prof. Vladimir Khavinson, the president of European Association of Gerontology and Geriatrics, the first class combination consists of Endoluten (Neuro-endocrine system), Vladonix (Immune system), Cerluten (Brain), Sigumir (Joints and Bones), Svetinorm (Liver) and Ventfort (Blood vessels) for one or two months twice a year. Endoluten and Vladonix are the two most important geroprotector that are able to extend life by 30-40%.

Here are some general recommendations:

 

Natural Peptides Combinations

• Digestive System: A-7 Svetinorm A-1 Suprefort A-10 Stamakort

• Cardiovascular system: A-3 Ventfort A-14 Chelochart A-6 Vladonix

• Central nervous system: A-5 Cerluten A-3 Ventfort A-7 Svetinorm

• Immune system: A-8 Endoluten A-6 Vladonix® A-3 Ventfort

• Locomotor apparatus: A-4 Sigumir A-3 Ventfort A-6 Vladonix A-21 Bonothyrk

• Carbohydrate metabolism disorders: A-1 Suprefort A-3 Ventfort

• Lipoprotein metabolism disorders: A-7 Svetinorm A-1 Suprefort A-3 Ventfort

• Thyroid gland: A-2 Thyreogen A-3 Ventfort

• Adverse factors (chemotherapy, long-term ionizing irradiation): A-6 Vladonix A-7 Svetinorm A-8 Endoluten A-20 Bonomarlot

• Adverse factors (professional or psychoemotional stress): A-6 Vladonix A-8 Endoluten A-17 Glandokort

• Visual organ: A-11 Visoluten A-5 Cerluten A-3 Ventfort

• Urinary excretory system: A-6 Vladonix A-12 Chitomur A-9 Pielotax

• Male reproductive system: A-13 Testoluten A-16 Libidon A-17 Glandokort

• Female reproductive system: A-15 Zhenoluten A-2 Thyreogen A-3 Ventfort

• Respiratory system: A-6 Vladonix A-19 Taxorest A-3 Ventfort

• Intensive physical activity: A-6 Vladonix A-4 Sigumir A-3 Ventfort A-18 Gotratix A-5 Cerluten

 

 

Clinical Study Of Vladonix® Peptide Bio-regulator

The dietary supplement Vladonix contains a complex of low-molecular peptides with molecular weight up to 5000 Da, isolated from thymus of young animals - calves aged up to 12 months. Vladonix is manufactured in the form of capsules with a content of active substances 10 mg.

Experimental studies have shown that the peptides possess tissue-specific action on the cells of the tissues from which they were isolated. Vladonix peptides regulate metabolism processes in the immune system cells, they restore the immunological reactivity that has been infringed; stimulate regeneration processes in case of their inhibition. Thus it is possible to extrapolate efficiency of Vladonix for restoration of immune system function at different purulent-inflammatory and other diseases, characterized by suppression of the immune status of the patients.

It is well known, that various factors of physical, chemical and biological nature depending on duration and intensity of their influence on human organism, can result in deterioration of adaptation and compensatory mechanisms and may cause profound disorders of various segments of the immune protection system (2, 3). Pathological changes of the immune system, as a rule, results in long-term course of basic disease with a tendency to relapses, reduction in resistance of the organism to infections and severe complications.

Among the drugs, promoting recovery of immunological reactivity, are immunomodulator drugs of various origin: enzyme preparations (tripsin, lysocim), bacterial polysaccharides (pyrogenal, prodigiosan), yeast polysaccharides (zymosan, glucanes, prepermil, dextranes), vaccines (BCG), nucleic acid preparations (sodium nucleinate), purine and pyrimidine derivatives, levamisol, diucifon, traditional medicine preparations and many others (1, 2).

The clinical studies of Vladonix were carried out at the Medical Center of the Saint Petersburg Institute of Bioregulation and Gerontology in patients after long-term low-dose ionizing radiation influence, including oncological patients after radiation and chemotherapy during the period from November 2005 till February 2006.

 

The subjects of the clinical studies were 42 patients (23 men and 19 women) - apart from general purpose medicines they were taking Vladonix per os before meal 1-3 capsules 2-3 times a day for 15-20 days depending on a degree of immune status disturbances. The patients of the control group have been taking general purpose medicines only. The age of patients has made from 34 up to 65 years. Distribution of the patients by clinical entities, sex and age is shown in the table 1.

Table 1

Distribution of the patients by clinical entities, sex and age

 

Examination
Vladonix efficiency was assessed by changes of the patients’ complaints and by the number of objective parameters: general clinical analysis of blood and urine, immunological study of peripheral blood (number of T- and B-lymphocytes was determined by immunofluorescence method with monoclonal antibodies to differentiation lymphocyte antigens CD3, CD4, CD8, CD20; content of various classes immunoglobulins - using a method of radial immune diffusion in a gel using Mancini method; functional activity of T-lymphocytes - using leukocyte migration inhibition test (LMIT) with ConA).

The tests performed have shown, that 92 % of persons, living in the environmentally neglected territory, have immune status disorders in the form of decrease in the number of CD3+, CD4+cells, at insufficient increase in the number of lymphocytes with CD8+phenotype, which is a sign of decrease of the immune reactivity level (CD4+/CD8+). The results of LMIT with ConA characterize a decrease in functional activity of T-lymphocytes (mostly CD8+, i.e. T-suppressors/killers). The number of CD20+-cells, being a subpopulation of B-lymphocytes, was not different from normal values, but at the same time there was an increase in the number of M and G immunoglobulins in blood serum (table 2).

It is important to note that quantitative indicators of content of CD3+ and CD4+ cells are typical for lower limits of physiological changes of their number in the patients of such age that is a possible sign of premature ageing of the immune system. As a rule people with secondary immune-deficiency condition has intense asthenic syndrome and considerable changes of cardiovascular system.

Table 2

Vladonix influence of the cellular and humoral immunity parameters in patients, who have undergone low-dose ionizing radiation influence

 

The results of the test performed provide strong evidence of the fact, that Vladonix is an effective mean for correction of secondary immune deficiency, being a response to influence of extreme factors. Administration of Vladonix together with symptomatic means has helped to normalize infringed parameters of immune system in 78 % of cases. According to the data provided, the highest effect observed of Vladonix administration was identified in subpopulations of T-lymphocytes and in their functional activity (reliable increase in the number of CD3+- and CD4+-lymphocytes, normalization of CD4+/CD8+ratio). Less intense reaction was notices in B-system, probably, due to its higher conservativity.

After the treatment course using Vladonix, the patients, which have noticed considerable improvement of general condition and decrease in intensity of asthenic syndrome, always parallel to secondary immune deficiency. Oncological patients after radiation and chemotherapy had increased normalization of immunological indices, which resulted in improvement of general condition and decrease in the rate of complications. What stands out in the report is the fact, that patients of the basic group tolerated radiation and chemotherapy better and was able to finish the whole course of treatment (control group – 79 %).

Conclusion
Clinical studies have shown, that Vladonix promotes normalization of cellular immunity parameters, stimulated tissue regeneration processes in case of their inhibition, does not result in any side effects, complications and drug dependence, and can be used for treatment and prophylaxis in parallel with any means of symptomatic and pathogenetic therapy, used for correction of secondary immune deficiency conditions (immune modulators, adaptogens, vitamins etc.). Vladonix is recommended for acceleration of restoration of the immune system functions after the infectious diseases, radiation and chemotherapy, influence on the organism of various extreme factors (including ionizing and UHF-radiation). It’s also recommended to elderly people for maintenance of the immune system function.

It is recommended to take Vladonix per os 10-15 minutes before meal 1-3 capsules, 2-3 times a day for 20-30 days. It may be desired to have one more course in 3-6 months. The clinical study showed no side effects, complications, contraindications and drug dependence of Vladonix.

References
1. Drannik G.N., Grinevich Y.A., Disik G.M. Immunotropic preparations. - Kiev Zdorov’ya, 1994. - 288 pages.
2. Mashkovsky M.D. Medicines: Pharmacotherapy for doctors, manual: 2 parts. - Vilnius: ZAO “Gamta”, 1993.
3. Novikov V.S., Smirnov V.S. Immune physiology of extreme conditions. - SPb.: Nauka, 1995. - 172 pages.
4. Schek M.G., Kosinets A.N., Adamenko G.P. Immunological aspects of surgical infection. - Vitebsk: B. i., 1994. - 140 pages

 

Please note: You should always consult a primary care physician/health practitioner of choice when considering the use of any products for health purposes, especially when undergoing treatment for an existing condition.